Condition: Sarcoma,Soft Tissue · Sarcoma · Sarcoma of Bone · Sponsor: Shanxi Province Cancer Hospital
Evaluation of the efficacy and safety of Xidabenzamide combined with AK112 for advanced bone and soft tissue sarcoma of second-line and above.
This description comes directly from the study's public registry record.
Xin Wang, Dr · +86 138 1117 6181 · WXCAMS@126.com
Rui Wang, Dr · 18234142488 · 240013861@qq.com
Always discuss trial participation with your own doctor first.
| Shanxi Cancer Hospital | Taiyuan, Shanxi, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06637007